Skip to main content
Log in

Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management

  • Review Article
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Niemann-Pick disease type C (NPC) is a lysosomal storage disorder that presents with a spectrum of clinical manifestations from infancy and childhood or in early or mid-adulthood. Progressive neurological symptoms including ataxia, dystonia and vertical gaze palsy are a hallmark of the disease, and psychiatric symptoms such as psychosis and mood disorders are common. These latter symptoms often present early in the course of NPC and thus these patients are often diagnosed with a major psychotic or affective disorder before neurological and cognitive signs present and the diagnosis is revised. The commonalities and characteristics of psychotic symptoms in both NPC and schizophrenia may share neuronal pathways and mechanisms and provide potential targets for research in both disorders. The neurobiology of NPC and its relationship to the pattern of neuropsychiatric and cognitive symptoms is described in this review. A number of neurobiological models are proposed as mechanisms by which NPC causes psychiatric and cognitive symptoms, informed from models proposed in schizophrenia and other metabolic disorders. There are a number of symptomatic and illness-modifying treatments for NPC currently available. The current evidence is discussed; focussing on two medications which have shown promise, miglustat and hydroxypropyl-β-cyclodextrin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sévin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, et al. The adult form of Niemann-Pick disease type C. Brain. 2007;130:120–33.

    Article  PubMed  Google Scholar 

  2. Wassif CA, Cross JL, Iben J, Sanchez-pulido L, Platt FM, Ory DS, et al. High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1 predicted by analysis of massively parallel sequencing data sets. Genet Med. 2016;18:41–8.

    Article  CAS  PubMed  Google Scholar 

  3. Walterfang M, Fietz M, Fahey M, Sullivan D, Leane P, Lubman DI, et al. The neuropsychiatry of Niemann-Pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci. 2006;18:158–70. https://doi.org/10.1176/jnp.2006.18.2.158.

    Article  PubMed  Google Scholar 

  4. Vanier MT. Complex lipid trafficking in Niemann-Pick disease type C. J Inherit Metab Dis. 2014;38:187–99.

    Article  CAS  PubMed  Google Scholar 

  5. Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab. 2012;106:330–44.

    Article  CAS  PubMed  Google Scholar 

  6. Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5:16.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bonnot O, Klünemann H-H, Velten C, Torres Martin JV, Walterfang M. Systematic review of psychiatric signs in Niemann-Pick disease type C. World J Biol Psychiatry. 2018. https://doi.org/10.1080/15622975.2018.1441548.

    Article  PubMed  Google Scholar 

  8. Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis. 2013;8:1–10.

    Article  Google Scholar 

  9. Imrie J, Vijayaraghaven S, Whitehouse C, Harris S, Heptinstall L, Church H, et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis. 2002;25:491–500.

    Article  CAS  PubMed  Google Scholar 

  10. Imrie J, Heptinstall L, Knight S, Strong K. Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database. BMC Neurol. 2015;15:257.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jahnova H, Dvorakova L, Vlaskova H, Hulkova H, Poupetova H, Hrebicek M, et al. Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years. Orphanet J Rare Dis. 2014;9:140.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis. 2007;30:631–41.

    Article  CAS  PubMed  Google Scholar 

  13. Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 2007;6:765–72.

    Article  CAS  PubMed  Google Scholar 

  14. Pineda M, Walterfang M, Patterson MC. Miglustat in Niemann-Pick disease type C patients: a review. Orphanet J Rare Dis. 2018;13:140.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wijburg FA, Sedel F, Pineda M, Hendriksz CJ, Fahey M, Walterfang M, et al. Development of a Suspicion Index to aid diagnosis of Niemann-Pick disease type C. Neurology. 2012;78:1560–7.

    Article  CAS  PubMed  Google Scholar 

  16. Vanier MT, Gissen P, Bauer P, Coll MJ, Burlina A, Hendriksz CJ, et al. Diagnostic tests for Niemann-Pick disease type C (NP-C): a critical review. Mol Genet Metab. 2016;118:244–54. https://doi.org/10.1016/j.ymgme.2016.06.004.

    Article  CAS  PubMed  Google Scholar 

  17. Bonnot O, Klünemann HH, Sedel F, Tordjman S, Cohen D, Walterfang M. Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J Rare Dis. 2014;9:65.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bowman EA, Walterfang M, Abel L, Desmond P, Fahey M, Velakoulis D. Longitudinal changes in cerebellar and subcortical volumes in adult-onset Niemann-Pick disease type C patients treated with miglustat. J Neurol. 2015;262:2106–14.

    Article  CAS  PubMed  Google Scholar 

  19. Abel LA, Walterfang M, Stainer MJ, Bowman EA, Velakoulis D. Longitudinal assessment of reflexive and volitional saccades in Niemann-Pick type C disease during treatment with miglustat. Orphanet J Rare Dis. 2015;10:1–8. https://doi.org/10.1186/s13023-015-0377-8.

    Article  Google Scholar 

  20. Bowman EA, Velakoulis D, Desmond P, Walterfang M. Longitudinal changes in white matter fractional anisotropy in adult-onset Niemann-Pick disease type C patients treated with miglustat. JIMD Rep. 2018;39:39–43. https://doi.org/10.1007/8904_2017_42.

    Article  PubMed  Google Scholar 

  21. Arenas F, Garcia-Ruiz C, Fernandez-Checa JC. Intracellular cholesterol trafficking and impact in neurodegeneration. Front Mol Neurosci. 2017;10:382.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Benussi A, Cotelli MS, Padovani A, Borroni B. Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC. F1000Res. 2018;7:194.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann-Pick disease type C. Brain. 1995;118:119–29.

    Article  PubMed  Google Scholar 

  24. Suzuki K, Parker CC, Pentchev PG, Katz D, Ghetti B, D’Agostino AN, et al. Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol. 1995;89:227–38.

    Article  CAS  PubMed  Google Scholar 

  25. Hung YH, Faux NG, Killilea DW, Yanjanin N, Firnkes S, Volitakis I, et al. Altered transition metal homeostasis in Niemann-Pick disease, type C1. Metallomics. 2014;6:542–53.

    Article  CAS  PubMed  Google Scholar 

  26. Fu R, Yanjanin NM, Elrick MJ, Ware C, Lieberman AP, Porter FD. Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1. Am J Med Genet Part A. 2012;158A:2775–80.

    Article  CAS  PubMed  Google Scholar 

  27. Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Malnar M, Hecimovic S, Mattsson N, Zetterberg H. Bidirectional links between Alzheimer’s disease and Niemann-Pick type C disease. Neurobiol Dis. 2014;72:37–47.

    Article  CAS  PubMed  Google Scholar 

  29. Auer IA, Schmidt ML, Lee VM-Y, Curry B, Suzuki K, Shin R-W, et al. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer’s disease. Acta Neuropathol. 1995;90:547–51.

    Article  CAS  PubMed  Google Scholar 

  30. Bergeron D, Poulin S, Laforce R. Cognition and anatomy of adult Niemann-Pick disease type C: insights for the Alzheimer field. Cogn Neuropsychol. 2018;35(3–4):209–22.

    Article  PubMed  Google Scholar 

  31. Bu B, Klunemann H, Suzuki K, Li J, Bird T, Jin LW, et al. Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol Dis. 2002;11(2):285–97.

    Article  CAS  PubMed  Google Scholar 

  32. Baudry M, Yao Y, Simmons D, Liu J, Bi X. Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp Neurol. 2003;184:887–903.

    Article  CAS  PubMed  Google Scholar 

  33. German DC, Liang C-L, Song T, Yazdani U, Xie C, Dietschy JM. Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience. 2002;109:437–50.

    Article  CAS  PubMed  Google Scholar 

  34. Williams IM, Wallom KL, Smith DA, Al Eisa N, Smith C, Platt FM. Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice. Neurobiol Dis. 2014;67:9–17. https://doi.org/10.1016/j.nbd.2014.03.001.

    Article  CAS  PubMed  Google Scholar 

  35. Platt N, Speak AO, Colaco A, Gray J, Smith DA, Williams IM, et al. Immune dysfunction in Niemann-Pick disease type C. J Neurochem. 2016;136:74–80.

    Article  CAS  PubMed  Google Scholar 

  36. Yu T, Lieberman AP. Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin. PLoS Genet. 2013;9:e1003462.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Takikita S, Fukuda T, Mohri I, Yagi T, Suzuki K. Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse. J Neuropathol Exp Neurol. 2004;63:660–73.

    Article  PubMed  Google Scholar 

  38. Goodrum JF, Pentchev PG. Cholesterol reutilization during myelination of regenerating PNS axons is impaired in Niemann-Pick disease type C mice. J Neurosci Res. 1998;49:389–92.

    Article  Google Scholar 

  39. Yan X, Yadav R, Gao M, Weng H-R. Interleukin-1 beta enhances endocytosis of glial glutamate transporters in the spinal dorsal horn through activating protein kinase C. Glia. 2014;62:1093–109.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Pacheco CD, Kunkel R, Lieberman AP. Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects. Hum Mol Genet. 2007;16:1495–503.

    Article  CAS  PubMed  Google Scholar 

  41. Walkley SU, Baker HJ, Rattazzi MC, Haskins ME, Wu J-Y. Neuroaxonal dystrophy in neuronal storage disorders: evidence for major GABAergic neuron involvement. J Neurol Sci. 1991;104:1–8.

    Article  CAS  PubMed  Google Scholar 

  42. Zervas M, Dobrenis K, Walkley SU. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol. 2001;60:49–64.

    Article  CAS  PubMed  Google Scholar 

  43. Yamada A, Saji M, Ukita Y, Shinoda Y, Taniguchi M, Higaki K, et al. Progressive neuronal loss in the ventral posterior lateral and medial nuclei of thalamus in Niemann-Pick disease type C mouse brain. Brain Dev. 2001;23:288–97.

    Article  CAS  PubMed  Google Scholar 

  44. Lopez ME, Klein AD, Dimbil UJ, Scott MP. Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder. J Neurosci. 2011;31:4367–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Pressey SNR, Smith DA, Wong AMS, Platt FM, Cooper JD. Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice. Neurobiol Dis. 2012;45:1086–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Trouard TP, Heidenreich RA, Seeger JF, Erickson RP. Diffusion tensor imaging in Niemann-Pick Type C disease. Pediatr Neurol. 2005;33(5):325–30.

    Article  PubMed  Google Scholar 

  47. Walterfang M, Fahey M, Desmond P, Wood A, Seal ML, Steward C, et al. White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology. 2010;75:49–56.

    Article  CAS  PubMed  Google Scholar 

  48. Lee R, Apkarian K, Jung ES, Yanjanin N, Yoshida S, Mori S, et al. Corpus callosum diffusion tensor imaging and volume measures are associated with disease severity in pediatric Niemann-Pick disease type C1. Pediatr Neurol. 2014;51(669–674):e5.

    Google Scholar 

  49. Masingue M, Adanyeguh I, Nadjar Y, Sedel F, Galanaud D, Mochel F. Evolution of structural neuroimaging biomarkers in a series of adult patients with Niemann-Pick type C under treatment. Orphanet J Rare Dis. 2017;12:22.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Walterfang M, Macfarlane MD, Looi JCL, Abel L, Bowman E, Fahey MC, et al. Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. Eur J Neurol. 2012;19:462–7.

    Article  CAS  PubMed  Google Scholar 

  51. Walterfang M, Patenaude B, Abel LA, Kluenemann H, Bowman EA, Fahey MC, et al. Subcortical volumetric reductions in adult niemann-pick disease type C: a cross-sectional study. Am J Neuroradiol. 2013;34:1334–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Walterfang M, Bonnot O, Mocellin R, Velakoulis D. The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis. 2013;36(4):687–702.

    Article  CAS  PubMed  Google Scholar 

  53. Lau MW, Lee RW, Miyamoto R, Jung ES, Yanjanin Farhat N, Yoshida S, et al. Role of diffusion tensor imaging in prognostication and treatment monitoring in Niemann-Pick disease type C1. Diseases. 2016;4(3):29.

    Article  CAS  PubMed Central  Google Scholar 

  54. Walterfang M, Abel LA, Desmond P, Fahey MC, Bowman EA, Velakoulis D. Cerebellar volume correlates with saccadic gain and ataxia in adult Niemann-Pick type C. Mol Genet Metab. 2013;108:85–9.

    Article  CAS  PubMed  Google Scholar 

  55. Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab. 2009;98:152–65.

    Article  CAS  PubMed  Google Scholar 

  56. Shulman LM, David NJ, Weiner WJ. Psychosis as the initial manifestation of adult-onset Niernann-Pick disease type C. Neurology. 1996;45:1739–43.

    Article  Google Scholar 

  57. Campo JV, Robert S, Greg S, Debra B, Barbara G. Psychosis as a presentation of physical disease in adolescence: a case of Niemann-Pick disease, type C. Dev Med Child Neurol. 2008;40:126–9.

    Article  Google Scholar 

  58. Josephs KA, Van Gerpen MW, Van Gerpen JA. Adult onset Niemann-Pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry. 2003;74:528–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Sandu S, Jackowski-Dohrmann S, Ladner A, Haberhausen M, Bachmann C. Niemann-Pick disease type C1 presenting with psychosis in an adolescent male. Eur Child Adolesc Psychiatry. 2009;18:583–5.

    Article  PubMed  Google Scholar 

  60. Walterfang M, Fietz M, Abel L, Bowman E, Mocellin R, Velakoulis D. Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann-Pick disease type C. J Inherit Metab Dis. 2009;32:221–6.

    Article  Google Scholar 

  61. Walterfang M, Kornberg A, Adams S, Fietz M, Velakoulis D. Post-ictal psychosis in adolescent Niemann-Pick disease type C. J Inherit Metab Dis. 2010;33:63–5.

    Article  Google Scholar 

  62. Wouters S, De Meirleir L, Campforts E, Lampo A. Psychosis in an adolescent girl: a common manifestation in Niemann-Pick type C disease. Child Adolesc Psychiatry Ment Health. 2014;8:20.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Maubert A, Hanon C, Metton J. Niemann-Pick type C disease and psychosis: two siblings. Encephale. 2015;41:238–43.

    Article  CAS  PubMed  Google Scholar 

  64. Rebelo J, Oliveira M, Nunes P. Psychiatric manifestations of Niemann-Pick type C disease—two case reports. Eur Psychiatry. 2016;33:S466.

    Article  Google Scholar 

  65. Szakszon K, Szegedi I, Magyar Á, Oláh É, Andrejkovics M, Balla P, et al. Complete recovery from psychosis upon miglustat treatment in a juvenile Niemann-Pick C patient. Eur J Paediatr Neurol. 2014;18:75–8.

    Article  PubMed  Google Scholar 

  66. Koens LH, Kuiper A, Coenen MA, Elting JWJ, de Vries JJ, Engelen M, et al. Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C. Orphanet J Rare Dis. 2016;11:121.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Kawazoe T, Yamamoto T, Narita A, Ohno K, Adachi K, Nanba E, et al. Phenotypic variability of Niemann-Pick disease type C including a case with clinically pure schizophrenia: a case report. BMC Neurol. 2018;18:117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Baumgartner A, Nia S, Geiblinger S, Baumgartner C. Psychiatric manifestation of adult form of Niemann-Pick type C. A case report. J Neurol Sci. 2013;333:e705.

    Article  Google Scholar 

  69. Maubert A, Hanon C, Sedel F. Psychiatric disorders in adult form of Niemann-Pick disease type C. Encephale. 2016;42:208–13.

    Article  CAS  PubMed  Google Scholar 

  70. Bonnot O, Gama CS, Mengel E, Pineda M, Vanier MT, Watson L, et al. Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): findings from the International NPC Registry. World J Biol Psychiatry. 2017;9:1–10.

    Google Scholar 

  71. Walterfang M, Bonnot O, Mocellin R, Velakoulis D. The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis. 2013;36:687–702.

    Article  CAS  PubMed  Google Scholar 

  72. Sullivan D, Walterfang M, Velakoulis D. Bipolar disorder and Niemann-Pick disease type C. Am J Psychiatry. 2005;162:1021–2.

    Article  PubMed  Google Scholar 

  73. Bonnot O, Herrera P, Tordjman S, Walterfang M. Secondary psychosis induced by metabolic disorders. Front Neurosci. 2015;9:177.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Lossos A, Schlesinger I, Okon E, Al E. Adult-onset niemann-pick type c disease: clinical, biochemical, and genetic study. Arch Neurol. 1997;54:1536–41.

    Article  CAS  PubMed  Google Scholar 

  75. Abel LA, Walterfang M, Fietz M, Bowman EA, Velakoulis D. Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits. Neurology. 2009;72:1083–6.

    Article  CAS  PubMed  Google Scholar 

  76. Chien Y-H, Lee N-C, Tsai L-K, Huang A-C, Peng S-F, Chen S-J, et al. Treatment of Niemann-Pick disease type C in two children with miglustat: Initial responses and maintenance of effects over 1 year. J Inherit Metab Dis. 2007;30:826.

    Article  PubMed  Google Scholar 

  77. Chien YH, Peng SF, Yang CC, Lee NC, Tsai LK, Huang AC, et al. Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C. J Inherit Metab Dis. 2013;36:129–37.

    Article  CAS  PubMed  Google Scholar 

  78. Johnen A, Pawlowski M, Duning T. Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia. Orphanet J Rare Dis. 2018;13(1):91.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Walterfang M, Siu R, Velakoulis D. The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients. Aust N Z J Psychiatry. 2006;40:995–1002.

    Article  PubMed  Google Scholar 

  80. Hinton V, Vecchio D, Prady H, Wraith E, Patterson M, York N, et al. The cognitive phenotype of Niemann-Pick type C (NPC): neuropsychological characteristics of patients at baseline in a clinical trial with oral miglustat [abstract no. OPL120]. J Neurol Sci. 2005;238:S77.

    Google Scholar 

  81. Klarner B, Klünemann HH, Lürding R, Aslanidis C, Rupprecht R. Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations. J Inherit Metab Dis. 2007;30:60–7.

    Article  CAS  PubMed  Google Scholar 

  82. Heitz C, Epelbaum S, Nadjar Y. Cognitive impairment profile in adult patients with Niemann pick type C disease. Orphanet J Rare Dis. 2017;12(1):166.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Hendriksz CJ, Anheim M, Bauer P, Bonnot O, Chakrapani A, Corvol JC, et al. The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease. Curr Med Res Opin. 2017;33:877–90.

    Article  PubMed  Google Scholar 

  84. Schiffmann R. Niemann-Pick disease type C: from bench to bedside. JAMA. 1996;276:561–4.

    Article  CAS  PubMed  Google Scholar 

  85. Shulman LM, Lang AE, Jankovic J, David NJ, Weiner WJ. What is it? Case 1, 1995: psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction. Mov Disord. 1995;10:257–62.

    Article  CAS  PubMed  Google Scholar 

  86. Salmon DP. Disorders of memory in Alzheimer’s disease. In: Cermak LS, editor. Handbook of neuropsychology: memory and its disorders, vol. 2. 2nd ed. Amsterdam: Elsevier Science Publishers B.V.; 2000. p. 155–95.

    Google Scholar 

  87. Dardis A, Zampieri S, Canterini S, Newell KL, Stuani C, Murrell JR, et al. Altered localization and functionality of TAR DNA Binding Protein 43 (TDP-43) in Niemann-Pick disease type C. Acta Neuropathol Commun. 2016;4:52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Zhang M, Hallows JL, Wang X, Bu B, Wang W, Vincent I. Mitogen-activated protein kinase activity may not be necessary for the neuropathology of Niemann-Pick type C mice. J Neurochem. 2008;107:814–22.

    Article  CAS  PubMed  Google Scholar 

  89. Velakoulis D, Walterfang M, Mocellin R, Pantelis C, McLean C. Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry. 2009;194:298–305.

    Article  CAS  PubMed  Google Scholar 

  90. Cooper JJ, Ovsiew F. The relationship between schizophrenia and frontotemporal dementia. J Geriatr Psychiatry Neurol. 2013;26:131–7.

    Article  PubMed  Google Scholar 

  91. Harvey PD. Cognitive impairment in schizophrenia: characteristics, assessment and treatment. Cambridge: Cambridge University Press; 2013.

    Book  Google Scholar 

  92. O’Carroll R. Cognitive impairment in schizophrenia. Adv Psychiatr Treat. 2000;6:161–8.

    Article  Google Scholar 

  93. Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. 2006;2:531–6.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Evans WRH, Hendriksz CJ. Niemann-Pick type C disease – the tip of the iceberg? A review of neuropsychiatric presentation, diagnosis and treatment. BJPsych Bull. 2017;41:109–14.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Saudubray J-M. Neurometabolic disorders. J Inherit Metab Dis. 2009;32:595.

    Article  PubMed  Google Scholar 

  96. Walterfang M, Mocellin R, Velakoulis D. The neuropsychiatry of neuroendocrine and neurometabolic disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock’s comprehensive psychiatry. 11th ed. Philadelphia: Lippincott; 2009.

    Google Scholar 

  97. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:593–602.

    Article  PubMed  Google Scholar 

  98. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA. 2004;101:8174–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6:309–15.

    Article  CAS  PubMed  Google Scholar 

  100. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN, et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science. 1999;283:1908–11.

    Article  CAS  PubMed  Google Scholar 

  101. Walterfang M, Wood SJ, Velakoulis D, Copolov D, Pantelis C. Diseases of white matter and schizophrenia-like psychosis. Aust N Z J Psychiatry. 2005;39:746–56.

    Article  PubMed  Google Scholar 

  102. Friston K, Frith C. Schizophrenia: a disconnection syndrome? Clin Neurosci. 1995;3(2):89–97.

    CAS  PubMed  Google Scholar 

  103. Wernicke C (1906) Grundrisse der Psychiatrie. Leipzig: Thieme.

    Google Scholar 

  104. Bleuler E, [Transl. Zinkin J]. Dementia praecox, or the group of schiozophrenias. New York: International Universities Press; 1950.

    Google Scholar 

  105. Walterfang M, Wood SJ, Velakoulis D, Pantelis C. Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neurosci Biobehav Rev. 2006;30:918–48.

    Article  PubMed  Google Scholar 

  106. Broyd SJ, Demanuele C, Debener S, Helps SK, James CJ, Sonuga-Barke EJS. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev. 2009;33:279–96.

    Article  PubMed  Google Scholar 

  107. Zalesky A, Fornito A, Seal ML, Cocchi L, Westin CF, Bullmore ET, et al. Disrupted axonal fiber connectivity in schizophrenia. Biol Psychiatry. 2011;69:80–9.

    Article  PubMed  Google Scholar 

  108. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy: insights into the neurobiology of psychosis. Arch Neurol. 1992;49:401–6.

    Article  CAS  PubMed  Google Scholar 

  109. Black DN, Taber KH, Hurley RA. Metachromatic leukodystrophy: a model for the study of psychosis. J Neuropsychiatry Clin Neurosci. 2003;15:289–93.

    Article  PubMed  Google Scholar 

  110. Kikinis Z, Asami T, Bouix S, Finn CT, Ballinger T, Tworog-Dube E, et al. Reduced fractional anisotropy and axial diffusivity in white matter in 22q11.2 deletion syndrome: a pilot study. Schizophr Res. 2012;141:35–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Jalbrzikowski M, Villalon-Reina JE, Karlsgodt KH, Senturk D, Chow C, Thompson PM, et al. Altered white matter microstructure is associated with social cognition and psychotic symptoms in 22q11.2 microdeletion syndrome. Front Behav Neurosci. 2014;8:1–18.

    Article  Google Scholar 

  112. Crapse TB, Sommer MA. Corollary discharge across the animal kingdom. Nat Rev Neurosci. 2008;9:587–600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Feinberg I. Efference copy and corollary discharge: implications for thinking and its disorders. Schizophr Bull. 1978;4:636–40.

    Article  CAS  PubMed  Google Scholar 

  114. Frith CD (2014) The cognitive neuropsychology of schizophrenia. London: Psychology Press (First published 1992).

    Book  Google Scholar 

  115. Whitford TJ, Ford JM, Mathalon DH, Kubicki M, Shenton ME. Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr Bull. 2012;38:486–94.

    Article  PubMed  Google Scholar 

  116. Blakemore S, Wolpert D, Frith C. Abnormalities in the awareness and control of action. Philos Trans R Soc B Biol Sci. 2000;355:1771–88.

    Article  Google Scholar 

  117. Lemaitre AL, Luyat M, Lafargue G. Individuals with pronounced schizotypal traits are particularly successful in tickling themselves. Conscious Cogn. 2016;41:64–71.

    Article  PubMed  Google Scholar 

  118. Rottach KG, Von Maydell RD, Das VE, Zivotofsky AZ, Discenna AO, Gordon JL, et al. Evidence for independent feedback control of horizontal and vertical saccades from Niemann-Pick type C disease. Vis Res. 1997;37:3627–38.

    Article  CAS  PubMed  Google Scholar 

  119. Leigh RJ, Kennard C. Using saccades as a research tool in the clinical neurosciences. Brain. 2004;127:460–77.

    Article  CAS  PubMed  Google Scholar 

  120. Klauser P, Baker ST, Cropley VL, Bousman C, Fornito A, Cocchi L, et al. White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs. Schizophr Bull. 2017;43:425–35.

    PubMed  Google Scholar 

  121. Friston K, Brown HR, Siemerkus J, Stephan KE. The dysconnection hypothesis (2016). Schizophr Res. 2016;176:83–94.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Stahl SM. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectr. 2018;23:187–91.

    Article  PubMed  Google Scholar 

  123. Hu CY, Ong WY, Patel SC. Regional distribution of NPC1 protein in monkey brain. J Neurocytol. 2000;29:765–73.

    Article  CAS  PubMed  Google Scholar 

  124. Xu S, Chen X, Wei X, Liu G, Wang Q. Presynaptic impairment in Niemann-Pick C1-deficient neurons: not dependent on presence of glial cells. Neurosci Lett. 2011;496:54–9.

    Article  CAS  PubMed  Google Scholar 

  125. Brachet A, Norwood S, Brouwers JF, Palomer E, Helms JB, Dotti CG, et al. LTP-triggered cholesterol redistribution activates Cdc42 and drives AMPA receptor synaptic delivery. J Cell Biol. 2015;208(6):791–806.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Frank C, Rufini S, Tancredi V, Forcina R, Grossi D, D’Arcangelo G. Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus. Exp Neurol. 2008;212:407–14.

    Article  CAS  PubMed  Google Scholar 

  127. Zhou S, Xu S, Yan Y, Yu H, Ling S, Luo J. Decreased purinergic inhibition of synaptic activity in a mouse model of Niemann-Pick disease type C. Hippocampus. 2011;21:212–9.

    Article  PubMed  Google Scholar 

  128. D’Arcangelo G, Grossi D, Racaniello M, Cardinale A, Zaratti A, Rufini S, et al. Miglustat reverts the impairment of synaptic plasticity in a mouse model of NPC disease. Neural Plast. 2016;2016:3830424.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Xu S, Zhou S, Xia D, Xia J, Chen G, Duan S, et al. Defects of synaptic vesicle turnover at excitatory and inhibitory synapses in Niemann-Pick C1-deficient neurons. Neuroscience. 2010;167:608–20.

    Article  CAS  PubMed  Google Scholar 

  130. Buard I, Pfrieger FW. Relevance of neuronal and glial NPC1 for synaptic input to cerebellar Purkinje cells. Mol Cell Neurosci. 2014;61:65–71.

    Article  CAS  PubMed  Google Scholar 

  131. Joyce DW, Averbeck BB, Frith CD, Shergill SS. Examining belief and confidence in schizophrenia. Psychol Med. 2013;43:2327–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Fletcher PC, Frith CD. Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nat Rev Neurosci. 2008;10:48–58.

    Article  CAS  PubMed  Google Scholar 

  133. Sporns O, Honey CJ, Kötter R. Identification and classification of hubs in brain networks. PLoS ONE. 2007;2:e1049.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Crossley NA, Mechelli A, Scott J, Carletti F, Fox PT, McGuire P, et al. The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain. 2014;137:2382–95.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Tomasi D, Wang G-J, Volkow ND. Energetic cost of brain functional connectivity. Proc Natl Acad Sci USA. 2013;110:13642–7.

    Article  PubMed  PubMed Central  Google Scholar 

  136. van den Heuvel MP, Sporns O, Collin G, Albert E. Abnormal rich club organization and functional brain dynamics in schizophrenia. JAMA Psychiatry. 2013;70:783–92.

    Article  PubMed  Google Scholar 

  137. German DC, Quintero EM, Liang C-L, Ng B, Punia S, Xie C, et al. Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. J Comp Neurol. 2001;433:415–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  138. Taniguchi M, Shinoda Y, Ninomiya H, Vanier MT, Ohno K. Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain. Brain Dev. 2001;23:414–21.

    Article  CAS  PubMed  Google Scholar 

  139. Higashi Y, Murayama S, Pentchev PG, Suzuki K. Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol. 1993;85:175–84.

    Article  CAS  PubMed  Google Scholar 

  140. Habas C, Kamdar N, Nguyen D, Keller K, Beckmann CF, Menon V, et al. Distinct cerebellar contributions to intrinsic connectivity networks. J Neurosci. 2009;29:8586–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. Wang L, Zou F, Shao Y, Ye E, Jin X, Tan S, et al. Disruptive changes of cerebellar functional connectivity with the default mode network in schizophrenia. Schizophr Res. 2014;160:67–72.

    Article  PubMed  Google Scholar 

  142. Tamminga CA, Stan AD, Wagner AD. The hippocampal formation in schizophrenia. Am J Psychiatry. 2010;167:1178–93.

    Article  PubMed  Google Scholar 

  143. Heckers S, Konradi C. Hippocampal neurons in schizophrenia. J Neural Transm. 2002;109:891–905.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Velakoulis D, Wood SJ, Wong MH, Albert E. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra–high-risk individuals. Arch Gen Psychiatry. 2006;63:139–49.

    Article  PubMed  Google Scholar 

  145. Tregellas JR, Smucny J, Harris JG, Olincy A, Maharajh K, Kronberg E, et al. Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia. Am J Psychiatry. 2014;171:549–56.

    Article  PubMed  PubMed Central  Google Scholar 

  146. Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, et al. Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Mol Psychiatry. 2018;23(8):1764–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Behrendt R-P. Contribution of hippocampal region CA3 to consciousness and schizophrenic hallucinations. Neurosci Biobehav Rev. 2010;34:1121–36.

    Article  PubMed  Google Scholar 

  148. Treiber-Held S, Distl R, Meske V, Albert F, Ohm TG. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer’s disease. J Pathol. 2003;200:95–103.

    Article  CAS  PubMed  Google Scholar 

  149. D’Arcangelo G, Grossi D, De Chiara G, De Stefano MC, Cortese G, Citro G, et al. Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease. Brain Res. 2011;1396:11–9.

    Article  CAS  PubMed  Google Scholar 

  150. Nagai M, Kishi K, Kato S. Insular cortex and neuropsychiatric disorders: a review of recent literature. Eur Psychiatry. 2007;22(6):387–94.

    Article  CAS  PubMed  Google Scholar 

  151. Crespo-Facorro B, Kim J-J, Andreasen NC, O ’leary DS, Bockholt HJ, Magnotta V. Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res. 2000;46:35–43.

    Article  CAS  PubMed  Google Scholar 

  152. Shergill SS, Brammer MJ, Williams SC, Murray RM, Mcguire PK. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry. 2000;57:1033–8.

    Article  CAS  PubMed  Google Scholar 

  153. Dougherty M, Lazar J, Klein JC, Diaz K, Gobillot T, Grunblatt E, et al. Genome sequencing in a case of Niemann-Pick type C. Cold Spring Harb Mol Case Stud. 2016;2:a001222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Pergola G, Selvaggi P, Trizio S, Bertolino A, Blasi G. The role of the thalamus in schizophrenia from a neuroimaging perspective. Neurosci Biobehav Rev. 2015;54:57–75.

    Article  PubMed  Google Scholar 

  155. Simpson EH, Kellendonk C, Kandel E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron. 2010;65:585–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  156. Ramnani N. The primate cortico-cerebellar system: anatomy and function. Nat Rev Neurosci. 2006;7:511–22.

    Article  CAS  PubMed  Google Scholar 

  157. Schmahmann J, Pandya D. The cerebrocerebellar system. Int Rev Neurobiol. 1997;41:31–60.

    Article  CAS  PubMed  Google Scholar 

  158. Buckner RL. The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron. 2013;80:807–15.

    Article  CAS  PubMed  Google Scholar 

  159. Schmahmann JD. An emerging concept: the cerebellar contribution to higher function. Arch Neurol. 1991;48:1178–87.

    Article  CAS  PubMed  Google Scholar 

  160. Bellebaum C, Daum I. Cerebellar involvement in executive control. Cerebellum. 2007;6:184–92.

    Article  PubMed  Google Scholar 

  161. Schmahmann J, Sherman J. The cerebellar cognitive affective syndrome. Brain. 1998;121:561–79.

    Article  PubMed  Google Scholar 

  162. Halassa MM, Kastner S. Thalamic functions in distributed cognitive control. Nat Neurosci. 2017;20:1669–79.

    Article  CAS  PubMed  Google Scholar 

  163. Saalmann YB, Kastner S. The cognitive thalamus. Front Syst Neurosci. 2015;9:39.

    Article  PubMed  PubMed Central  Google Scholar 

  164. Parnaudeau S, Bolkan SS, Kellendonk C. The mediodorsal thalamus: an essential partner of the prefrontal cortex for cognition. Biol Psychiatry. 2018;83:648–56.

    Article  PubMed  Google Scholar 

  165. Simeone JC, Ward AJ, Rotella P, Collins J, Windisch R. An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review. BMC Psychiatry. 2015;15:193.

    Article  PubMed  PubMed Central  Google Scholar 

  166. MacQueen GM, Rosebush PI, Mazurek MF. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci. 1998;10:10–9.

    Article  CAS  PubMed  Google Scholar 

  167. Karimzadeh P, Jafari N, Nejad Biglari H, Jabbehdari S, Khayat Zadeh S, Ahmad Abadi F, et al. Neurometabolic diagnosis in children who referred as neurodevelopmental delay (a practical criteria, in Iranian pediatric patients). Iran J Child Neurol. 2016;10:73–81.

    PubMed  PubMed Central  Google Scholar 

  168. Kohlschütter A, Eichler F. Childhood leukodystrophies: a clinical perspective. Expert Rev Neurother. 2011;11:1485–96.

    Article  PubMed  Google Scholar 

  169. Maubert A, Hanon C, Metton J. Adult onset Niemann-Pick type C disease and psychosis: literature review. Encephale. 2013;39:315–9.

    Article  CAS  PubMed  Google Scholar 

  170. Seo Y, Shin Y, Kim H-S, Kang I, Hong I-S, Choi SW, et al. Donepezil enhances Purkinje cell survival and alleviates motor dysfunction by inhibiting cholesterol synthesis in a murine model of Niemann pick disease type C. J Neuropathol Exp Neurol. 2014;73:234–43.

    Article  CAS  PubMed  Google Scholar 

  171. Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, et al. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab. 2009;98:243–9. https://doi.org/10.1016/j.ymgme.2009.07.003.

    Article  CAS  PubMed  Google Scholar 

  172. Santos MLF, Raskin S, Telles DS, Löhr Junior A, Liberalesso PBN, Vieira SC, et al. Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil. J Inherit Metab Dis. 2008;31:357–61.

    Article  Google Scholar 

  173. Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, et al. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Mol Genet Metab. 2010;99:351–7.

    Article  CAS  PubMed  Google Scholar 

  174. Fecarotta S, Romano A, Della Casa R, Del Giudice E, Bruschini D, Mansi G, et al. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C. Orphanet J Rare Dis. 2015;10:22.

    Article  PubMed  PubMed Central  Google Scholar 

  175. Liu B. Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease. Clin Lipidol. 2012;7:289–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  176. Vite CH, Bagel JH, Swain GP, Prociuk M, Sikora TU, Stein VM, et al. Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease. Sci Transl Med. 2015;7:276ra26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  177. Ory DS, Ottinger EA, Farhat NY, King KA, Jiang X, Weissfeld L, et al. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial. Lancet. 2017;390:1758–68. https://doi.org/10.1016/S0140-6736(17)31465-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  178. Berry-Kravis E, Chin J, Hoffmann A, Winston A, Stoner R, LaGorio L, et al. Long-term treatment of Niemann-Pick type C1 disease with intrathecal 2-hydroxypropyl-β-cyclodextrin. Pediatr Neurol. 2018;80:24–34.

    Article  PubMed  PubMed Central  Google Scholar 

  179. Megías-Vericat JE, García-Robles A, Company-Albir MJ, Fernández-Megía MJ, Pérez-Miralles FC, López-Briz E, et al. Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases. Neurol Sci. 2017;38:727–43.

    Article  PubMed  Google Scholar 

  180. Vtesse Inc, a Mallinckrodt Pharmaceuticals Company. Study of VTS-270 (2-hydroxypropyl-β-cyclodextrin) to treat Niemann-Pick type C1 (NPC1) disease [ClinicalTrials.gov identifier NCT02534844]. National Institutes of Health, ClinicalTrials.gov. 2018. https://clinicaltrials.gov/ct2/show/NCT02534844. Accessed 11 Dec 2018.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Rego.

Ethics declarations

Funding

Funding was received for medical illustrations for this article from an unrestricted educational grant provided by the Royal Melbourne Hospital.

Conflict of interest

Thomas Rego, Sarah Farrand, Anita M.Y. Goh, Dhamidhu Eratne, Wendy Kelso, Simone Mangelsdorf, Dennis Velakoulis and Mark Walterfang have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rego, T., Farrand, S., Goh, A.M.Y. et al. Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management. CNS Drugs 33, 125–142 (2019). https://doi.org/10.1007/s40263-018-0599-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40263-018-0599-0

Navigation